AMAG Pharma (AMAG) Posts Smaller Q4 Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to AMAG Pharma (AMAG) Posts Smaller Q4 Loss

AMAG Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update

February 7, 2019 7:01 AM EST

Reaffirms 2019 Financial Guidance and Announces Consolidation of Womens Health and Maternal Health Sales Forces

Conference Call Scheduled for 8:00 a.m. ET Today

WALTHAM, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the fourth quarter and full year ended December 31, 2018, which were in-line with previously announced preliminary results.

Total revenues from continuing operations for the full year of 2018 totaled $474.0 million, including record annual revenue of $135.0 million from Feraheme® (ferumoxytol injection), annual revenue of $322.3 million from Makena®... More